Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC

NCT07076979 · clinicaltrials.gov ↗
RECRUITING
Status
250
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Shanghai Minimally Invasive Surgery Center